Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Comparison of disease activity measures in early psoriatic arthritis in usual care.

Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M.

Rheumatology (Oxford). 2019 Jun 18. pii: kez215. doi: 10.1093/rheumatology/kez215. [Epub ahead of print]

PMID:
31211399
2.

Association of Physical Activity and Medication with Enthesitis on Ultrasound in Psoriatic Arthritis.

Wervers K, Herrings I, Luime JJ, Tchetverikov I, Gerards AH, Hazes JMW, Vis M.

J Rheumatol. 2019 Mar 1. pii: jrheum.180782. doi: 10.3899/jrheum.180782. [Epub ahead of print]

PMID:
30824661
3.

Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis.

Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M; Cicero.

Arthritis Res Ther. 2019 Jan 16;21(1):25. doi: 10.1186/s13075-019-1811-4.

4.

Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study.

van Bentum RE, Heslinga SC, Nurmohamed MT, Gerards AH, Griep EN, Koehorst CBJM, Kok MR, Schilder AM, Verhoef M, van der Horst-Bruinsma IE.

J Rheumatol. 2019 Feb;46(2):153-159. doi: 10.3899/jrheum.180312. Epub 2018 Nov 1.

5.

Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis.

Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M.

J Rheumatol. 2018 Nov;45(11):1526-1531. doi: 10.3899/jrheum.171406. Epub 2018 Jul 1.

PMID:
29961685
6.

Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.

Wervers K, Vis M, Tchetveriko I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Luime JJ.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1764-1770. doi: 10.1002/acr.23571.

7.

Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Ten Cate DF, Jacobs JWG, Swen WAA, Hazes JMW, de Jager MH, Basoski NM, Haagsma CJ, Luime JJ, Gerards AH.

Arthritis Res Ther. 2018 Jan 30;20(1):15. doi: 10.1186/s13075-018-1514-2.

8.

Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers.

Wervers K, Vis M, Rasappu N, van der Ven M, Tchetverikov I, Kok MR, Gerards AH, Hazes J, Luime JJ.

Scand J Rheumatol. 2018 Jul;47(4):291-294. doi: 10.1080/03009742.2017.1393695. Epub 2018 Jan 2.

PMID:
29291671
9.

Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis.

van der Ven M, van der Veer-Meerkerk M, Ten Cate DF, Rasappu N, Kok MR, Csakvari D, Hazes JMW, Gerards AH, Luime JJ.

Arthritis Res Ther. 2017 Sep 15;19(1):202. doi: 10.1186/s13075-017-1405-y.

10.

Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors.

Lamers-Karnebeek FB, Luime JJ, Ten Cate DF, Teerenstra S, Swen NWAA, Gerards AH, Hendrikx J, van Rooyen EM, Voorneman R, Haagsma C, Basoski N, de Jager M, Ghiti Moghadam M, Efde MN, Goekoop-Ruiterman YPM, van Riel PLCM, Jacobs JWG, Jansen TL.

Rheumatology (Oxford). 2017 Sep 1;56(9):1560-1565. doi: 10.1093/rheumatology/kex184.

PMID:
28595367
11.

No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.

van der Ven M, Kuijper TM, Gerards AH, Tchetverikov I, Weel AE, van Zeben J, Hazes JM, Luime JJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1276-1281. doi: 10.1093/rheumatology/kex080.

PMID:
28407127
12.

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.

de Jong PH, Hazes JM, Buisman LR, Barendregt PJ, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE.

Rheumatology (Oxford). 2016 Dec;55(12):2138-2147. Epub 2016 Aug 30.

PMID:
27581208
13.

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.

Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE.

Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9.

PMID:
27283332
14.

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

van der Ven M, Alves C, Luime JJ, Gerards AH, Barendregt PJ, van Zeben D, van Schaeybroeck B, de Sonnaville PB, Grillet BA, Hazes JM.

Rheumatology (Oxford). 2016 Apr;55(4):636-9. doi: 10.1093/rheumatology/kev383. Epub 2015 Nov 4.

PMID:
26538422
15.

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2.

16.

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

de Jong PH, Hazes JM, Han HK, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, van Schaeybroeck B, de Sonnaville PB, van Krugten MV, Luime JJ, Weel AE.

Ann Rheum Dis. 2014 Jul;73(7):1331-9. doi: 10.1136/annrheumdis-2013-204788. Epub 2014 May 1.

17.

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.

de Rotte MC, den Boer E, de Jong PH, Pluijm SM, Ćalasan MB, Weel AE, Huisman AM, Gerards AH, van Schaeybroeck B, Wulffraat NM, Lindemans J, Hazes JM, de Jonge R.

Ann Rheum Dis. 2015 Feb;74(2):408-14. doi: 10.1136/annrheumdis-2013-203725. Epub 2013 Dec 2.

PMID:
24297383
18.

Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.

van der Heijden JW, Assaraf YG, Gerards AH, Oerlemans R, Lems WF, Scheper RJ, Dijkmans BA, Jansen G.

Scand J Rheumatol. 2014;43(1):9-16. doi: 10.3109/03009742.2013.797490. Epub 2013 Aug 30.

PMID:
23987246
19.

Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis--a systematic review of the literature.

Ten Cate DF, Luime JJ, Swen N, Gerards AH, De Jager MH, Basoski NM, Hazes JM, Haagsma CJ, Jacobs JW.

Arthritis Res Ther. 2013 Jan 8;15(1):R4. doi: 10.1186/ar4132. Review.

20.

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study.

de Jong PH, Quax RA, Huisman M, Gerards AH, Feelders RA, de Sonnaville PB, Luime JJ, Weel AE, Hazes JM.

Ann Rheum Dis. 2013 Oct;72(10):1659-63. doi: 10.1136/annrheumdis-2012-202152. Epub 2012 Oct 31.

PMID:
23117243
21.

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.

de Jong PH, Hazes JM, Barendregt PJ, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE.

Ann Rheum Dis. 2013 Jan;72(1):72-8. doi: 10.1136/annrheumdis-2011-201162. Epub 2012 Jun 7.

PMID:
22679301
22.

Brief Report: to squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis.

de Jong PH, Weel AE, de Man YA, Huisman AM, Gerards AH, van Krugten MV, Luime JJ, Hazes JM.

Arthritis Rheum. 2012 Oct;64(10):3095-101. doi: 10.1002/art.34568.

23.

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

van den Broek M, Dirven L, de Vries-Bouwstra JK, Dehpoor AJ, Goekoop-Ruiterman YP, Gerards AH, Kerstens PJ, Huizinga TW, Lems W, Allaart CF.

Ann Rheum Dis. 2012 Sep;71(9):1530-3. doi: 10.1136/annrheumdis-2011-201212. Epub 2012 Apr 24.

PMID:
22532630
24.

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.

PMID:
21813548
25.

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis.

Güler-Yüksel M, Klarenbeek NB, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van der Kooij SM, Gerards AH, Ronday HK, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF.

Arthritis Res Ther. 2010;12(3):R96. doi: 10.1186/ar3025. Epub 2010 May 20.

26.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35. doi: 10.1002/art.23364.

27.

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, van Groenendael JH, Hazes JM, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2007 Oct;66(10):1356-62. Epub 2007 Feb 9.

28.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2005 Nov;52(11):3381-90.

29.

Two inhibitors of DNA-synthesis lead to inhibition of cytokine production via a different mechanism.

de Lathouder S, Gerards AH, Dijkmans BA, Aarden LA.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1089-100. Review.

PMID:
15571208
30.

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.

Fraser AD, van Kuijk AW, Westhovens R, Karim Z, Wakefield R, Gerards AH, Landewé R, Steinfeld SD, Emery P, Dijkmans BA, Veale DJ.

Ann Rheum Dis. 2005 Jun;64(6):859-64. Epub 2004 Nov 4.

31.

Bioassay for detection of methotrexate in serum.

de Lathouder S, Gerards AH, de Groot ER, Valkhof MG, Dijkmans BA, Aarden LA.

Scand J Rheumatol. 2004;33(3):167-73.

PMID:
15228187
32.

Destructive joint disease in alpha-mannosidosis. A case report and review of the literature.

Gerards AH, Winia WP, Westerga J, Dijkmans BA, van Soesbergen RM.

Clin Rheumatol. 2004 Feb;23(1):40-2. Epub 2003 Nov 13.

PMID:
14749981
33.

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.

Gerards AH, de Lathouder S, de Groot ER, Dijkmans BA, Aarden LA.

Rheumatology (Oxford). 2003 Oct;42(10):1189-96. Epub 2003 May 30.

PMID:
12777636
34.

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Gerards AH, Landewé RB, Prins AP, Bruyn GA, Goei Thé HS, Laan RF, Dijkmans BA.

Ann Rheum Dis. 2003 Apr;62(4):291-6. Erratum in: Ann Rheum Dis. 2003 Nov;62(11):1126. Bruijn, GA [corrected to Bruyn, GA].

35.

Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.

de Lathouder S, Gerards AH, de Groot ER, Valkhof M, Aarden LA.

Eur Cytokine Netw. 2002 Jul-Sep;13(3):317-23.

36.

[A patient with generalized actinomycosis].

Gerards AH, van den Bosch J, van Henten MJ, van Meyel JJ.

Ned Tijdschr Geneeskd. 1997 Nov 22;141(47):2301-5. Dutch.

PMID:
9550816

Supplemental Content

Loading ...
Support Center